Authors
Latest:
Budget Impact of Everolimus in Treating Metastatic Renal Cell CarcinomaA decision-analytical model shows that everolimus has a favorable budget impact when introduced into the treatment algorithm for metastatic renal cell carcinoma.
Latest:
Real-World Dosing and Utilization of Ustekinumab Among Patients With PsoriasisThis study is an evaluation of the dosing patterns of ustekinumab among patients with psoriasis in a real-world setting.
Latest:
ASD and Medication Adherence: An Opportunity for Pharmacist InterventionUnfortunately, medication adherence in children with ASD is poor, particularly among children with chronic conditions or comorbid mental health conditions.
Latest:
Industry Voice: Asking For What You Want: It WorksAsk for what you want. Seems simple, right?
Latest:
The Value of Data in Specialty PharmacyData have different meanings and value for each of the key stakeholders in specialty pharmacy. Understanding the needs of each group will help improve outcomes and reduce expenses.
Latest:
Op-Ed: Why We Need a Health Promotion Screening Law in MassachusettsImplementing screening and testing services by pharmacists will expand access to care for patients.
Latest:
Examining the Role of REMS in Opioid SafetyAn expert questions why the risks and side effects of warfarin are explained much more carefully to patients than those of opioids.
Latest:
New Roles for Oncology PharmacistsThese pharmacists have specialized knowledge about pharmaceuticals and their use in treating cancer and its comorbidities, and they work collaboratively with the health care team to optimize outcomes.
Latest:
Costs of Collagenase Clostridium Histolyticum and Fasciectomy for Dupuytren's ContractureA retrospective cohort analysis was conducted to compare disease-specific healthcare resource utilization and the costs of collagenase clostridium histolyticum and fasciectomy among adult Dupuytren’s contracture patients.
Latest:
Large-Scale, Community-Based Trial of a Personalized Drug-Related Problem Rectification SystemA controlled trial of a system for rectifying and preventing drug-related problems was conducted to evaluate improvement in the efficiency of resource utilization.
Latest:
Acute Migraine Treatment Gets FDA Complete Response LetterRizaport is an oral film formulation of rizatriptan benzoate, the active drug in Maxalt, for patients with migraine who experience dysphagia or migraine-related nausea.
Latest:
Impact of Generic Drug Discount Programs on Managed Care OrganizationsGeneric drug discount programs, which differ across large chain pharmacies, may result in significant savings for managed care organizations.
Latest:
Clinical and Cost Outcomes of Buprenorphine Treatment in a Commercial Benefit Plan PopulationBuprenorphine treatment with and without induction was found to decrease costs and utilization in opioid-dependent benefciaries.
Latest:
Trends in Medication Utilization and the Cost of Treatment for GoutWith new drugs in the pipeline and the impact of updated FDA drug safety policies on colchicine, gout may no longer be inexpensive to treat.
Latest:
Letter: Creating a Moment of CareI truly enjoy and cherish when patients look into my eyes and see that there is no stereotyping, insensitivity, or indifference.
Latest:
Parkinson's Disease: Deep Brain StimulationThe intractable, neurodegenerative movement disorder Parkinson's disease has challenged clinicians since its identification in 1817.
Latest:
Digital Technology: An Effective Communication Tool for Pharmacy Staff During COVID-19The COVID-19 pandemic made a convincing argument to employers of having a robust and sound communication strategy to their employees.
Latest:
Acute Pain: Considerations in Geriatric PatientsAcute pain is the body's normal response to noxious stimuli.
Latest:
Lasmiditan For the Acute Treatment of Migraine: An Opportunity For PharmacistsDespite triptan availability as a migraine-specific rescue, the global burden of migraine morbidity remains high.
Latest:
Cancer Therapeutic Clinical Trials Supporting FDA Approval and Compendia InclusionEvidentiary standards for new or supplementary cancer therapeutic indication approvals by the FDA are consistent with off-label indication inclusions on Medicare-referenced compendia.
Latest:
Pharmacist Technicians Can Play Key Role in Push Toward Telemedicine During COVID-19 PandemicLessons from implementing electronic medical records should be heeded by allowing clinicians to focus on patient care and by delegating the management of telemedicine to support staff, such as pharmacy technicians.
Latest:
Point-of-Care Testing Offers New OpportunitiesConsider these steps for pharmacists to further evolve their role as the pandemic continues to put pressure on the health care system.
Latest:
Contributions of Pharmacists in the Treatment of Epilepsy: A Systematic ReviewThe treatment of epilepsy is complex and can cause drug-related problems and hamper quality of life. Clinical services performed by pharmacists may optimize the pharmacotherapy and avoid or mitigate these problems.
Latest:
Cannabidiol Presents ConundrumsRecent federal legalization and increases sales of CBD underscore the importance of considering its pharmacologic impact.
Latest:
Vaccines Play a Role in Cancer TreatmentThere Is Room for Improvement in Treating Malignancies Caused by Infectious Agents, Especially Considering the Cost Differential
Latest:
Management of Long-Term Cancer Care CostsOral cancer treatments provide new opportunities for improved overall survival rates, but patients are increasingly responsible for higher out-of-pocket costs as they self-manage their therapy.
Latest:
Pilot Study in Drug Shortages Evaluates Oncology Patient Awareness, Management PreferencesOncology drugs have especially fallen victim to chronic shortages, consequently affecting the availability of substitute agents.
